Maynard Um
-
-
-
-
-
-
-
Piper Sandler on Oruka Therapeutics (ORKA): 'We remain bullish into a catalyst-rich year+'
-
-
-
-
-
-
-
Oruka Therapeutics (ORKA) PT Raised to $200 at Guggenheim
-
-
-
-
-
-
-
Oruka Therapeutics (ORKA) PT Raised to $70 at H.C. Wainwright
-
-
-
-
-
-
-
Piper Sandler on Oruka Therapeutics (ORKA): 'Now Is the Time to Own the Name'
-
-
-
-
-
-
-
Oruka Therapeutics adds Chris Martin to board, Cameron Turtle resigns
-
-
-
-
-
-
-
Oruka Therapeutics (ORKA) files $500M mixed shelf
-
-
-
-
-
-
-
Oruka Therapeutics (ORKA) Misses Q2 EPS by 46c
-
448,109 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

